Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Posted on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Sanaz Ahmadi | Diagnosis of Infectious Diseases | Best Researcher Award

Researcher | Academic Center for Education, Culture and Research | Iran

Dr. Sanaz Ahmadi Ghezeldasht is a distinguished researcher and molecular biologist at the Molecular Biology Section, Central Laboratory ACECR, Mashhad, Iran, specializing in medical immunology, molecular virology, and infectious diseases. She holds a Ph.D. in Medical Immunology from Mashhad University of Medical Sciences, an M.Sc. in Animal Physiology from Payam-e-Noor University of Isfahan, and a B.Sc. in Biology from Ferdowsi University of Mashhad. Dr. Ghezeldasht has served as the Supervisor of the Molecular Biology Center at Jahad Daneshgahi Mashhad, contributing to several national and international research projects focused on HTLV-1 pathogenesis, viral immunology, and host-virus interactions. Her prolific research portfolio encompasses numerous peer-reviewed publications in high-impact journals such as Reviews in Medical Virology, Journal of NeuroVirology, and Applied Biochemistry and Biotechnology, highlighting novel insights into viral oncogenesis, molecular diagnostics, and therapeutic development. A dedicated academic leader, she has organized and contributed to multiple scientific congresses and health monitoring initiatives. Dr. Ghezeldasht’s expertise extends to genetic engineering, bioinformatics, PCR technologies, and cell culture, complemented by certifications in English proficiency and advanced computer literacy. She is an active member of the HTLV-I Foundation and the Research Center for HIV/AIDS, HTLV, and Viral Hepatitis at ACECR, reflecting her enduring commitment to advancing molecular medicine and public health. Her scholarly impact is reflected by 409 citations across 26 publications with an h-index of 10.

Profiles: Scopus | ORCID

Featured Publication

1. Shafaei, A., Talebi, K., Zarean, M., Mosavat, A., Khajedaluee, A. R., Afzalaghaee, M., Shamsian, S. A. A., & Ghezeldasht, S. A. (2025). Intestinal parasitic infections, eosinophilia, and Th1/Th2 immune profiles in haemodialysis patients. Parasite Immunology.

2. Rahimzada, M., Nahavandi, M., Saffari, M., Shafaei, A., Mosavat, A., Ghezeldasht, S. A., Ariaee, N., Valizadeh, N., Rahimi, H., Rezaee, S. A., et al. (2023). Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia/lymphoma (ATLL). Molecular Biology Reports, 50(9).

3. Yousefpoor, N., Mahdavian, M., Pourbagher, Z., Ghezeldasht, S. A., Mosavat, A., Ziaee, M., Bahreini, M., Soleimanpour, S., Sharifmoghadam, M. R., Valizadeh, N., et al. (2023). Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region. Microbial Pathogenesis, 180, 106170.

4. Ghezeldasht, S. A., Bidkhori, H. R., Miri, R., Baghban, A., Mosavat, A., & Rezaee, S. A. (2023). Momordica charantia phytoconstituents can inhibit human T-lymphotropic virus type-1 (HTLV-1) infectivity in vitro and in vivo. Journal of NeuroVirology, 29(4), 567–578.

Mrs. Jing Wu | Infectious Diseases | Best Researcher Award

Posted on by Infectious

Mrs. Jing Wu | Infectious Diseases | Best Researcher Award

Nanjing First Hospital | China.

Author Profile

Scopus

🎓Education

Mrs. Jing Wu graduated from Nanjing Medical University, where she developed a strong foundation in imaging and diagnostic techniques.

💼Professional Experience

Currently, Mrs. Wu is a key member of the Department of Imaging at Nanjing Hospital, affiliated with Nanjing Medical University (Nanjing First Hospital). She specializes in respiratory imaging diagnosis and respiratory infection diagnosis, with extensive clinical and research experience.

🔬Technical Skills

Mrs. Wu is proficient in CT and MRI imaging, utilizing advanced techniques to diagnose and assess chest infections. She also has expertise in multidisciplinary team discussions and radiographic interpretation.

🔬Research Interests

Her research primarily focuses on chest infections, respiratory diseases, and advanced imaging techniques for diagnosis. She aims to improve diagnostic accuracy and treatment approaches for pulmonary conditions through innovative imaging.

📚Academic Contributions 

With over 20 published papers in prominent medical journals over the past five years, Mrs. Wu has significantly contributed to the field of respiratory imaging. Her notable works include articles on COVID-19 pneumonia, pulmonary infections, and Chlamydia psittaci pneumonia. Her impactful research can be found in journals like Eur Radiol, Quant Imaging Med Surg, and BMC Infect Dis.

🏅Achievements and Awards

Mrs. Wu has earned several prestigious awards, including the Second place in the China Radiographic Reading Competition and First prize in the Nanjing Medical University Young Doctor Lecture Competition. Her accolades showcase her leadership and expertise in radiology and chest imaging.

🎙️Teaching Experience

As a speaker at major conferences like the Chinese Radiology and Respiratory Annual Conference and the North American Radiology Conference, Mrs. Wu has shared her expertise in imaging diagnostics with peers and aspiring professionals.

📚Books & Reviews

Mrs. Wu has co-authored two professional books and served as the deputy editor-in-chief. She is also a dedicated peer reviewer for the Chinese Journal of Tuberculosis and Respiratory Medicine.

🌍Global Contributions

She continues to play a significant role in the international radiology community, sharing her research and findings to advance the field of respiratory imaging diagnostics.

Mrs. Wu’s exceptional skills and contributions make her a key figure in respiratory imaging diagnosis with a profound impact on clinical practice and medical education.

📑Notable Publications

“Chlamydia psittaci pneumonia – evolutionary aspects on chest CT”

Authors: Yang, N., Ou, Z., Sun, Q., Wu, J., Xue, C.
Publication Year: 2025
Journal: BMC Infectious Diseases

“Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China”

Authors: Deng, H., Shi, Y., Xie, M., Pan, L., Xue, X.
Publication Year: 2024
Journal: BMC Infectious Diseases

“Imaging analysis of pneumonic plague infection in Xizang, China: a case report and literature review”

Authors: Wang, W., Li, X., Wu, J., Fu, X., Li, B.
Publication Year: 2024
Journal: BMC Pulmonary Medicine

“CT and MRI Findings of Renal Angiomyolipoma With Lung Metastasis: A Case Report and Literature Review”

Authors: He, Z., Wu, J., Fu, X., Xu, H., Chen, Y.-C.
Publication Year: 2024
Journal: Clinical Respiratory Journal

“Clinical and CT diagnosis of 50 cases of Chlamydia psittaci pneumonia”

Authors: Wu, J., Pan, J., Han, C., Zhang, K., Chen, Y.-C.
Publication Year: 2023
Journal: Quantitative Imaging in Medicine and Surgery

Huali Xue | Disease Control | Best Researcher Award

Posted on by Infectious

Huali Xue | Disease Control | Best Researcher Award

Prof Dr. Huali Xue , Gansu Agricultural University, China.

Dr. Huali Xue is a distinguished researcher in the field of disease control, renowned for her groundbreaking work in public health and epidemiology. With a focus on infectious diseases, her research has significantly contributed to the development of innovative strategies for disease prevention and management. Recognized for her excellence and dedication to improving global health, Dr. Xue has earned the Best Researcher Award for her impactful studies, which continue to shape policies and interventions aimed at reducing the spread of diseases. Her expertise and leadership in the field have made her a key figure in advancing disease control efforts worldwide.

Professional Profiles

Scopus Profile

Orcid Profile

📚Education

Dr. Huali Xue holds a Ph.D. in Crop Protection from Gansu Agricultural University, China (2015), where she focused on the accumulation of trichothecenes in potato tubers and their induced resistance mechanisms. She earned a Master’s in Organic Chemistry from Northwest Normal University, China (2004), with research on the synthesis and photochromism of polymeric materials. Dr. Xue completed her Bachelor’s in Chemistry Education at Shanxi Datong University, China (2001), providing a strong foundation in both chemistry and education.

💼Experience

Dr. Huali Xue is currently a Professor at the College of Science, Gansu Agricultural University (2018-Present), where she has also held positions as Associate Professor (2012-2018) and Assistant Professor (2007-2012). She began her academic career as a Teaching Assistant at the university (2004-2007). Additionally, Dr. Xue was a Visiting Scholar at McGill University, Canada (2016-2017), further expanding her research expertise in plant protection and disease control. Throughout her career, she has contributed to both teaching and research in crop protection and plant pathology.

 

🔬Research Interest

Dr. Xue’s research investigates the molecular mechanisms of plant resistance to pathogens, with a particular focus on the regulation of trichothecene biosynthesis, oxidative stress responses in plants, and the detoxification of mycotoxins. Her projects explore the role of reactive oxygen species (ROS), calcium signaling, and plant defense pathways in mitigating disease and mycotoxin accumulation.

 

👩‍🏫Technical Skills

Dr. Xue is proficient in molecular biology techniques, proteomics, and the study of plant-pathogen interactions, focusing on trichothecenes, reactive oxygen species (ROS), and plant defense mechanisms. Her work also includes the development of strategies to reduce mycotoxin contamination in crops.

🎤Academic Citations & Presentations

Dr. Xue has presented at several international conferences, including the 10th International Congress of Plant Pathology (ICPP) in 2013, the International Mycotoxin Conference 2014 (ISM2014), and the III International Symposium on Postharvest Pathology in 2015, where she shared her research on trichothecene production and mycotoxin reduction in crops.

📑Top Note Publications

Title: TrSnt2-mediated histone H3 deacetylation governs mitophagy, ROS accumulation, ergosterol synthesis, and pathogenicity in Trichothecium roseum

Authors: Xu, X., Zong, Y., Wang, B., …, Prusky, D., Bi, Y.
Publication Year: 2024
Citations: 0

Title: Effects of TrPLDs on the pathogenicity of Trichothecium roseum infected apple fruit

Authors: Liu, Q., Zhang, Q., Xue, H., …, Liu, Z., Dov, P.
Publication Year: 2024
Citations: 0

Title: Trichothecium roseum epigenetic reader Snt2 in phenotype and pathogenicity regulation

Authors: Xu, X., Wang, B., Gong, D., …, Bi, Y., Zong, Y.
Publication Year: 2024
Citations: 0

Title: ROS mediated by TrPLD3 of Trichothecium roseum participated in cell membrane integrity of apple fruit by influencing phosphatidic acid metabolism

Authors: Zhang, Q., Liu, Q., Xue, H., …, Liu, Z., Prusky, D.
Publication Year: 2024
Citations: 4

Title: Ozone Application Suppressed the Blue Mold Development and Maintained the Main Active Ingredients Content of Postharvest Fresh Codonopsis pilosula during Storage

Authors: Chen, J., Liu, Z., Liu, Q., …, Shang, S., Bi, Y.
Publication Year: 2024
Citations: 1

Introduction of Animal Infectious Diseases

Posted on by Infectious

Introduction of Animal infectious diseases

Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species. These diseases can spread through direct contact between animals, contaminated water or food, vectors like insects, or environmental exposure.

Types of Animal Infectious Diseases

Viral Diseases:

Foot-and-Mouth Disease (FMD): Affects cloven-hoofed animals like cattle, sheep, and pigs. It's highly contagious and causes fever, blisters in the mouth and on feet, and can lead to severe economic losses.

Rabies: A fatal viral disease that affects the nervous system of mammals, including humans. It's transmitted through the saliva of infected animals, usually via bites.

Bacterial Diseases:

Anthrax: Caused by Bacillus anthracis, it affects cattle, sheep, and other herbivores, and can be transmitted to humans. It causes severe symptoms like sudden death in animals.

Brucellosis: Affects cattle, goats, and pigs, leading to reproductive issues like abortions. It can also be transmitted to humans, causing flu-like symptoms.

Parasitic Diseases:

Toxoplasmosis: Caused by the parasite Toxoplasma gondii, it can affect most warm-blooded animals, including humans. It often leads to neurological issues and reproductive problems.

Trypanosomiasis (Sleeping Sickness): Caused by Trypanosoma parasites, it's transmitted by tsetse flies and affects both animals and humans, leading to severe neurological issues.

Fungal Diseases:

Ringworm: A skin infection caused by various fungi, it affects many animals, including cattle, dogs, and cats. It causes circular patches of hair loss and skin irritation.

Transmission and Impact

Direct Transmission: Through physical contact, bites, or close proximity.

Indirect Transmission: Via contaminated feed, water, equipment, or bedding.

Vector-Borne Transmission: Carried by insects like ticks, mosquitoes, or flies.

Environmental Transmission: Through contaminated soil, water, or air.

These diseases can lead to significant economic losses in agriculture, reduce productivity, and in some cases, pose serious public health risks due to zoonotic transmission (diseases that can be transmitted from animals to humans).

Prevention and Control

Vaccination: Effective for preventing many viral and bacterial diseases.

Quarantine: Isolating infected animals to prevent the spread of disease.

Good Hygiene Practices: Regular cleaning and disinfection of animal housing, equipment, and environment.

Vector Control: Managing and reducing the population of disease-carrying insects.

Regular Monitoring and Surveillance: Early detection and response to outbreaks can prevent widespread infection.

Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

[post_grid id="9882"]